WHO Accused of Overstating Swine Flu Threat
Two reports released Friday are critical of the World Health Organization's handling of the H1N1 flu pandemic -- which was dubbed "exaggeration on stilts" -- as well as the fact that some WHO scientists had previously been on the payroll of big drug companies.
Two reports released Friday are critical of the World Health Organization’s handling of the H1N1 flu pandemic — which was dubbed “exaggeration on stilts” — as well as the fact that some WHO scientists had previously been on the payroll of big drug companies.
Critics say the WHO’s response sent the world into an unnecessary tizzy, wasting huge sums of money and provoking “unjustified fears” within the populace. — JCL
WAIT BEFORE YOU GO...Al Jazeera English:
A joint report into the handling of the H1N1 outbreak has found that some scientists who advised governments to stockpile drugs, had previously been on the payroll of big drug companies.
The report, published in the British Medical Journal, found World Health Organisation (WHO) guidelines on the use of medicine to treat the virus were prepared by experts who had received consulting fees from the top two manufacturers of the drugs — Roche and GlaxoSmithKline.
The WHO’s decision to name the flu a “pandemic” is also coming under scrutiny from European investigators, and stands accused of exaggerating the dangers of the H1N1 outbreak, which emerged in April last year.
This year, the ground feels uncertain — facts are buried and those in power are working to keep them hidden. Now more than ever, independent journalism must go beneath the surface.
At Truthdig, we don’t just report what's happening — we investigate how and why. We follow the threads others leave behind and uncover the forces shaping our future.
Your tax-deductible donation fuels journalism that asks harder questions and digs where others won’t.
Don’t settle for surface-level coverage.
Unearth what matters. Help dig deeper.
Donate now.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.